Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Posted on October 26th, 2016 by Jeffrey Paul, PhD in Pharma R&D
Cancer immunotherapy (especially checkpoint inhibitors) is hot in the cancer therapeutics world, but we are still learning about how best to use them and in which patients. The current explosion in new cancer immunotherapies relates to braking T-cell activation: checkpoint therapies. Continue reading “Immune Checkpoints: New Promises in Cancer Treatment” »
Posted on October 20th, 2016 by Betsy Davis in Pharma R&D
Drug discovery and development was once a very secretive process where the major industry players were intent on keeping their research to themselves in order to stay competitive.